| Name | Size | Creator | Creation Date | Labels | Comment | ||
|---|---|---|---|---|---|---|---|
| PNG File image-2024-4-24_9-16-17.png | 16 kB | Maria Braithwaite | 2024-Apr-24, 08:16 |
|
|||
| Version 1 (current) | 16 kB | Maria Braithwaite | 2024-Apr-24, 08:16 | ||||
| PNG File image-2024-3-18_8-0-5.png | 20 kB | Maria Braithwaite | 2024-Mar-18, 08:00 |
|
|||
| Version 1 (current) | 20 kB | Maria Braithwaite | 2024-Mar-18, 08:00 | ||||
| PDF File 20230809 BN Evaluation procedure to Observable entity v1.0 (1).pdf | 80 kB | Maria Braithwaite | 2024-Jan-16, 09:06 |
|
|||
| Version 1 (current) | 80 kB | Maria Braithwaite | 2024-Jan-16, 09:06 | ||||
| PDF File Briefing note - Implications of describing liquid dose form product concepts using presentation strength.pdf | 61 kB | Maria Braithwaite | 2023-Nov-16, 07:57 |
|
|||
| Version 1 (current) | 61 kB | Maria Braithwaite | 2023-Nov-16, 07:57 |
